Kennedy Paul, Wagner Mathilde, Castéra Laurent, Hong Cheng William, Johnson Curtis L, Sirlin Claude B, Taouli Bachir
From the Translational and Molecular Imaging Institute (P.K., B.T.) and Department of Radiology (B.T.), Icahn School of Medicine at Mount Sinai, 1470 Madison Ave, New York, NY 10029; Department of Radiology, Sorbonne Universités, UPMC, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France (M.W.); Department of Hepatology, University Paris-VII, Hôpital Beaujon, Clichy, France (L.C.); Liver Imaging Group, Department of Radiology, University of California-San Diego, San Diego, Calif (C.W.H., C.B.S.); Department of Biomedical Engineering, University of Delaware, Newark, Del (C.L.J.).
Radiology. 2018 Mar;286(3):738-763. doi: 10.1148/radiol.2018170601.
Chronic liver diseases often result in the development of liver fibrosis and ultimately, cirrhosis. Treatment strategies and prognosis differ greatly depending on the severity of liver fibrosis, thus liver fibrosis staging is clinically relevant. Traditionally, liver biopsy has been the method of choice for fibrosis evaluation. Because of liver biopsy limitations, noninvasive methods have become a key research interest in the field. Elastography enables the noninvasive measurement of tissue mechanical properties through observation of shear-wave propagation in the tissue of interest. Increasing fibrosis stage is associated with increased liver stiffness, providing a discriminatory feature that can be exploited by elastographic methods. Ultrasonographic (US) and magnetic resonance (MR) imaging elastographic methods are commercially available, each with their respective strengths and limitations. Here, the authors review the technical basis, acquisition techniques, and results and limitations of US- and MR-based elastography techniques. Diagnostic performance in the most common etiologies of chronic liver disease will be presented. Reliability, reproducibility, failure rate, and emerging advances will be discussed. RSNA, 2018 Online supplemental material is available for this article.
慢性肝病常导致肝纤维化,最终发展为肝硬化。治疗策略和预后因肝纤维化的严重程度不同而有很大差异,因此肝纤维化分期具有临床相关性。传统上,肝活检一直是评估纤维化的首选方法。由于肝活检存在局限性,非侵入性方法已成为该领域的关键研究热点。弹性成像能够通过观察感兴趣组织中的剪切波传播来无创测量组织的力学特性。肝纤维化分期增加与肝脏硬度增加相关,这为弹性成像方法提供了一个可利用的鉴别特征。超声(US)和磁共振(MR)成像弹性成像方法已商业化,各有其优缺点。在此,作者回顾了基于超声和磁共振弹性成像技术的技术基础、采集技术以及结果和局限性。还将介绍在慢性肝病最常见病因中的诊断性能。将讨论可靠性、可重复性、失败率和新进展。RSNA,2018 本文提供在线补充材料。